Viewing Study NCT05156905


Ignite Creation Date: 2025-12-25 @ 3:22 AM
Ignite Modification Date: 2026-01-09 @ 6:54 PM
Study NCT ID: NCT05156905
Status: TERMINATED
Last Update Posted: 2024-10-09
First Post: 2021-12-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer
Sponsor: University of California, San Diego
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module